These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 2789254)
21. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants. Byrne JA; Ahmed R; Oldstone MB J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788 [TBL] [Abstract][Full Text] [Related]
22. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells. Fresa KL; Karjalainen HE; Tevethia SS J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174 [TBL] [Abstract][Full Text] [Related]
23. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype. Green WR J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410 [TBL] [Abstract][Full Text] [Related]
24. The lysis of cytotoxic T lymphocytes and their blasts by cytotoxic T lymphocytes. Schick B; Berke G Immunology; 1990 Nov; 71(3):428-33. PubMed ID: 2269479 [TBL] [Abstract][Full Text] [Related]
25. The signal-anchor domain of adenovirus E3-6.7K, a type III integral membrane protein, can direct adenovirus E3-gp19K, a type I integral membrane protein, into the membrane of the endoplasmic reticulum. Wilson-Rawls J; Deutscher SL; Wold WS Virology; 1994 May; 201(1):66-76. PubMed ID: 8178490 [TBL] [Abstract][Full Text] [Related]
27. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure. Hiserodt JC J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707 [TBL] [Abstract][Full Text] [Related]
28. CTL escape viral variants. I. Generation and molecular characterization. Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078 [TBL] [Abstract][Full Text] [Related]
29. Relative immunogenicity of hepatitis B virus-encoded antigens as targets for cytotoxic T-cell response. Ishikawa T; Kakumu S; Yoshioka K; Yamada M; Tanaka K; Higashi Y; Takayanagi M; Okumura A; Kojima A; Tamura T Immunology; 1993 Oct; 80(2):313-8. PubMed ID: 8262560 [TBL] [Abstract][Full Text] [Related]
30. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. Hermiston TW; Tripp RA; Sparer T; Gooding LR; Wold WS J Virol; 1993 Sep; 67(9):5289-98. PubMed ID: 8350398 [TBL] [Abstract][Full Text] [Related]
31. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. V. H-2Ld self products are recognized by anti-AED-specific cytotoxic T cells. Levy RB; Shearer GM J Immunol; 1983 Apr; 130(4):1506-11. PubMed ID: 6187809 [TBL] [Abstract][Full Text] [Related]
32. The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. Gooding LR; Sofola IO; Tollefson AE; Duerksen-Hughes P; Wold WS J Immunol; 1990 Nov; 145(9):3080-6. PubMed ID: 2145367 [TBL] [Abstract][Full Text] [Related]
33. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation. Green WR J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246 [TBL] [Abstract][Full Text] [Related]
34. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host. Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802 [TBL] [Abstract][Full Text] [Related]
35. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes. Harris DT; Hale AH; Lefrancois L J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860 [TBL] [Abstract][Full Text] [Related]
36. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules. Hudrisier D; Oldstone MB; Gairin JE Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947 [TBL] [Abstract][Full Text] [Related]
37. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120 [TBL] [Abstract][Full Text] [Related]
38. Target determinants for F1 hybrid anti-parental H-2d cell-mediated lympholysis: self antigens controlled by the D end. Nakamura I; Nakano K; Cudkowicz G J Immunol; 1983 May; 130(5):2429-33. PubMed ID: 6187857 [TBL] [Abstract][Full Text] [Related]
39. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes. Holmes KV; Welsh RM; Haspel MV J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198 [TBL] [Abstract][Full Text] [Related]
40. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination. Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]